Gamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company's proprietary NAM technology.
http://technews.tmcnet.com/news/2013/02/14/6925197.htm
http://technews.tmcnet.com/news/2013/02/14/6925197.htm
No comments:
Post a Comment